AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 290: F177-F187, 2006. First published June 28, 2005; doi:10.1152/ajprenal.00056.2005
0363-6127/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/F177    most recent
00056.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasler, U.
Right arrow Articles by Martin, P.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasler, U.
Right arrow Articles by Martin, P.-Y.

Posttranscriptional control of aquaporin-2 abundance by vasopressin in renal collecting duct principal cells

Udo Hasler,1 Søren Nielsen,2 Eric Féraille,1,* and Pierre-Yves Martin1,*

1Service of Nephrology, Fondation pour Recherches Médicales, Geneva, Switzerland; and 2The Water and Salt Research Center, University of Aarhus, Aarhus, Denmark

Submitted 9 February 2005 ; accepted in final form 23 June 2005

Prevailing expression levels of aquaporin-2 (AQP2) mRNA play a major role in regulating AQP2 protein abundance. Here, we investigated whether AQP2 protein abundance is regulated at a posttranscriptional level as well. The expression levels of both AQP2 mRNA and protein increase in response to arginine vasopressin (AVP) in a concentration- and time-dependent manner in cultured immortalized mouse collecting duct principal cells (mpkCCDcl4 cells). AVP washout from the medium of AVP-pretreated cells revealed that AQP2 mRNA expression progressively decreased over time, whereas AQP2 protein abundance first increased immediately after AVP washout and then gradually decreased over time. Inversely, increasing AVP concentration led to a time-dependent increase of AQP2 mRNA, whereas AQP2 protein abundance first decreased immediately after AVP supplementation and then gradually increased over time. These transient effects arose from altered V2-receptor activity because they could be abolished by SR-121463B, a specific V2-receptor antagonist. Although cycloheximide administration had no effect on transient alterations of AQP2 protein content, these effects were attenuated by administration of chloroquine, a lysosomal inhibitor, or lactacystin, a proteasomal inhibitor. Short-term inhibition of PKA activity significantly increased AQP2 protein abundance and blunted the transient alterations of AQP2 protein content induced by AVP washout and supplementation. In addition, phosphorylated AQP2 abundance increased immediately after AVP supplementation. These results indicate that in response to AVP AQP2 protein abundance in collecting duct principal cells is principally influenced by AQP2 mRNA content but is additionally regulated by PKA-dependent negative feedback acting on AQP2 protein degradation.

arginine vasopressin; protein degradation



Address for reprint requests and other correspondence: E. Féraille, Service de Néphrologie, Fondation pour Recherches Médicales, 64 Ave. de la Roseraie, CH-1211, Genève 4, Switzerland (e-mail: Eric.Feraille{at}medecine.unige.ch)




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Boulkroun, D. Ruffieux-Daidie, J.-J. Vitagliano, O. Poirot, R.-P. Charles, D. Lagnaz, D. Firsov, S. Kellenberger, and O. Staub
Vasopressin-inducible ubiquitin-specific protease 10 increases ENaC cell surface expression by deubiquitylating and stabilizing sorting nexin 3
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F889 - F900.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Combet, S. Gouraud, R. Gobin, V. Berthonaud, G. Geelen, B. Corman, and J.-M. Verbavatz
Aquaporin-2 downregulation in kidney medulla of aging rats is posttranscriptional and is abolished by water deprivation
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1408 - F1414.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Machida, S. Wakamatsu, Y. Izumi, T. Yosifovska, T. Matsuzaki, Y. Nakayama, Y. Kohda, T. Inoue, H. Saito, K. Tomita, et al.
Downregulation of the V2 vasopressin receptor in dehydration: mechanisms and role of renal prostaglandin synthesis
Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1274 - F1282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. D. Hoffert, J. Nielsen, M.-J. Yu, T. Pisitkun, S. M. Schleicher, S. Nielsen, and M. A. Knepper
Dynamics of aquaporin-2 serine-261 phosphorylation in response to short-term vasopressin treatment in collecting duct
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F691 - F700.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
U. Hasler, U. S. Jeon, J. A. Kim, D. Mordasini, H. M. Kwon, E. Feraille, and P.-Y. Martin
Tonicity-Responsive Enhancer Binding Protein Is an Essential Regulator of Aquaporin-2 Expression in Renal Collecting Duct Principal Cells
J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1521 - 1531.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.